These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7897282)

  • 1. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
    Zhou L; Nishimoto S
    Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propargylic sulfones possessing a 2-nitroimidazole function: novel hypoxic-cell radiosensitizers with intracellular non-protein thiol depletion ability.
    Tanabe K; Kojima R; Hatta H; Nishimoto S
    Bioorg Med Chem Lett; 2004 May; 14(10):2633-5. PubMed ID: 15109667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidences for adduct formation between intracellular non-protein thiols and nitroazoles possessing an alpha,beta-unsaturated carbonyl side chain and the effects on radiosensitization of hypoxic cells.
    Zhou L; Ino A; Dai WM; Nishimoto S
    Bioorg Med Chem; 1999 Nov; 7(11):2591-8. PubMed ID: 10632069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
    Astor M; Hall EJ; Biaglow JE; Parham JC
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
    Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ
    J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thiols in cellular response to radiation and drugs.
    Biaglow JE; Varnes ME; Clark EP; Epp ER
    Radiat Res; 1983 Sep; 95(3):437-55. PubMed ID: 6684310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I; Stratford IJ; Jenkins TC
    Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers.
    Shibamoto Y; Nishimoto S; Shimokawa K; Hisanaga Y; Zhou L; Wang J; Sasai K; Takahashi M; Abe M; Kagiya T
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1045-8. PubMed ID: 2703384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyoxylic compounds as radiosensitizers of hypoxic cells.
    Cornago MP; Lopez Zumel MC; Alvarez MV; Izquierdo MC
    Biochem Med Metab Biol; 1990 Jun; 43(3):253-62. PubMed ID: 2383429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
    Watts ME; Jacobs RS
    Br J Cancer Suppl; 1978 Jun; 3():80-3. PubMed ID: 277262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
    Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
    J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Arylidene-4-cyclopentene-1,3-diones designed as non-nitro radiosensitizers and hypoxic cytotoxins.
    Hori H; Maezawa H; Iitaka Y; Ohsaka T; Shibata T; Mori T; Inayama S
    Jpn J Cancer Res; 1987 Oct; 78(10):1128-33. PubMed ID: 3119546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.
    Sakaguchi M; Webb MW; Agrawal KC
    J Med Chem; 1982 Nov; 25(11):1339-42. PubMed ID: 6890579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of a series of 3,5-disubstituted benzisoxazole-4,7-diones. Potent radiosensitizers in vitro.
    Suto MJ; Stier MA; Winters RT; Turner WR; Pinter CD; Elliott WE; Sebolt-Leopold JS
    J Med Chem; 1991 Nov; 34(11):3290-4. PubMed ID: 1956048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrotriazoles bearing sulfur-substituted side chains: preparation and characterization as hypoxic cell radiosensitizers.
    Sugita T; Masuoka M; Nishikawa Y; Nishimoto S; Zhou L; Sasai K; Kagiya T
    Anticancer Drug Des; 1992 Jun; 7(3):277-84. PubMed ID: 1610484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents.
    Jenkins TC; Stratford IJ; Stephens MA
    Anticancer Drug Des; 1989 Aug; 4(2):145-60. PubMed ID: 2803463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains.
    Adams GE; Ahmed I; Clarke ED; O'Neill P; Parrick J; Stratford IJ; Wallace RG; Wardman P; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Dec; 38(6):613-26. PubMed ID: 6970731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.